Anzeige
Mehr »
Lynx Broker
Login
Donnerstag, 22.08.2019 Börsentäglich über 12.000 News von 607 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
15:11Karyopharm down 1% premarket on publication of mid-stage selinexor data in treatment-resistant multiple myeloma-
14:58Retrophin Tanks After Neurological Treatment Fails Late-Stage Study-
14:34Research Solutions, Inc.: Research Solutions to Present at the 8th Annual Gateway Conference on September 4th-
14:31Retrophin Sinks as Drug "Pharma Bro" Martin Shkreli Co-Invented Fails1
14:08Retrophin's stock plunges after late-stage trial for PKAN treatment fails to meet targets1
14:01Incyte to Present at Upcoming Investor Conferences108Incyte Corporation (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September: Morgan Stanley 17th Annual Global Healthcare Conference...
► Artikel lesen
13:58Rocket Pharma's mid-stage FANCOLEN-II study of RP-L102 cleared in Spain1
13:39The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study1
13:22Retrophin's fosmetpantotenate flunks late-stage study in rare neurodegenerative disorder; shares down 25% premarket1
13:10Myriad Genetics, Inc.: Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related ...-
12:52Retrophin: Phase 3 FORT Study Fails To Meet Endpoints-
12:46UPDATE 1-Retrophin drug to treat nervous system disorder fails late-stage study1
12:46Retrophin neurological disorder drug misses late-stage study main goal-
12:35Retrophin, Inc. - 8-K, Current Report-
12:31BeiGene gets speedy US review for lymphoma drug zanubrutinib-
09:22Denmark's Novo Nordisk files lawsuit against Mylan over patent32
01:23BEIGENE (06160): INSIDE INFORMATION - BUSINESS UPDATES2
00:31Bayer Aktie & 975 Mio.€ Umsatz in Gefahr?! - Stellt Cannabis eine Alternative zu Aspirin dar?Aspirin ist wohl eines der bekanntesten und auch ältesten Medikamente weltweit. Bereits 1899 zählte Aspirin zu den ersten als Tablettenform verkäuflichen Medikamenten. Könnte nun nach 120 Jahren, das...
► Artikel lesen
MiKaryopharm Therapeutics Inc.: Karyopharm Announces Publication of XPOVIO (Selinexor) Phase 2b STORM Study Results ...3
MiKura Oncology files for $200M mixed shelf-
Seite:  Weiter >>